The human IL-23 receptor rs11209026 a allele promotes the expression of a soluble IL-23R-encoding mRNA species

Journal of Immunology

Volumn 194, Issue 3, 2015, Pages 1062-1068

  Yu, Raymond Y ^a   Brazaitis, Jonathan ^a   Gallagher, Grant ^a  

^a HUMIGEN LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; MESSENGER RNA; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; NUCLEAR PROTEIN; PROTEIN BINDING; RNA BINDING PROTEIN; SERINE-ARGININE-RICH SPLICING PROTEINS;

ALLELE; ALPHA CHAIN; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENHANCER REGION; EXON SKIPPING; GENE EXPRESSION; HUMAN; HUMAN CELL; IL23R GENE; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; RNA SPLICING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TH17 CELL; ALTERNATIVE RNA SPLICING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM;

ALLELES; ALTERNATIVE SPLICING; BINDING SITES; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; OLIGORIBONUCLEOTIDES, ANTISENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; RNA-BINDING PROTEINS; TH17 CELLS;

EID: 84921473604     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401850     Document Type: Article

References (39)

1. Rubio, J. P., J. Stankovich, J. Field, N. Tubridy, M. Marriott, C. Chapman, M. Bahlo, D. Perera, L. J. Johnson, B. D. Tait, et al. 2008. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun. 9: 624-630.
2. Han, J. W., H. F. Zheng, Y. Cui, L. D. Sun, D. Q. Ye, Z. Hu, J. H. Xu, Z. M. Cai, W. Huang, G. P. Zhao, et al. 2009. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41: 1234-1237.
3. Zhang, X. J., W. Huang, S. Yang, L. D. Sun, F. Y. Zhang, Q. X. Zhu, F. R. Zhang, C. Zhang, W. H. Du, X. M. Pu, et al. 2009. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat. Genet. 41: 205-210.
4. Gestermann, N., A. Mekinian, E. Comets, P. Loiseau, X. Puechal, E. Hachulla, J. E. Gottenberg, X. Mariette, and C. Miceli-Richard. 2010. STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling. Genes Immun. 11: 432-438.
5. Alcina, A., K. Vandenbroeck, D. Otaegui, A. Saiz, J. R. Gonzalez, O. Fernandez, M. L. Cavanillas, M. C. Cénit, R. Arroyo, I. Alloza, et al. 2010. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun. 11: 439-445.
6. Budarf, M. L., P. Goyette, G. Boucher, J. Lian, R. R. Graham, J. O. Claudio, T. Hudson, D. Gladman, A. E. Clarke, J. E. Pope, et al. 2011. A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun. 12: 51-58.
7. Vandenbroeck, K., I. Alloza, B. Swaminathan, A. Antigüedad, D. Otaegui, J. Olascoaga, M. G. Barcina, V. de las Heras, M. Bartolomé, M. Fernández-Arquero, et al. 2011. Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon b therapy and human herpes virus-6 infection. Genes Immun. 12: 40-45.
8. Shey, M. S., A. K. Randhawa, M. Bowmaker, E. Smith, T. J. Scriba, M. de Kock, H. Mahomed, G. Hussey, T. R. Hawn, and W. A. Hanekom. 2010. Single nucleotide polymorphisms in Toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion. Genes Immun. 11: 561-572.
9. Broux, B., N. Hellings, K. Venken, J. L. Rummens, K. Hensen, B. Van Wijmeersch, and P. Stinissen. 2010. Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor a gene influences the frequency of recent thymic emigrants. Genes Immun. 11: 326-333.
10. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
11. Cargill, M., S. J. Schrodi, M. Chang, V. E. Garcia, R. Brandon, K. P. Callis, N. Matsunami, K. G. Ardlie, D. Civello, J. J. Catanese, et al. 2007. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80: 273-290.
12. Faragó, B., L. Magyari, E. Sáfrány, V. Csöngei, L. Járomi, K. Horvatovich, C. Sipeky, A. Maász, J. Radics, A. Gyetvai, et al. 2008. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann. Rheum. Dis. 67: 248-250.
13. Huber, A. K., E. M. Jacobson, K. Jazdzewski, E. S. Concepcion, and Y. Tomer. 2008. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 93: 1077-1081.
14. Rahman, P., R. D. Inman, D. D. Gladman, J. P. Reeve, L. Peddle, and W. P. Maksymowych. 2008. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum. 58: 1020-1025.
15. Rahman, P., R. D. Inman, W. P. Maksymowych, J. P. Reeve, L. Peddle, and D. D. Gladman. 2009. Association of interleukin 23 receptor variants with psoriatic arthritis. J. Rheumatol. 36: 137-140.
16. de Paus, R. A., D. van de Wetering, J. T. van Dissel, and E. van de Vosse. 2008. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants. Mol. Immunol. 45: 3889-3895.
17. Di Meglio, P., A. Di Cesare, U. Laggner, C. C. Chu, L. Napolitano, F. Villanova, I. Tosi, F. Capon, R. C. Trembath, K. Peris, and F. O. Nestle. 2011. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS ONE 6: e17160.
18. + human T-cell functional responses. Proc. Natl. Acad. Sci. USA 108: 9560-9565.
19. Pidasheva, S., S. Trifari, A. Phillips, J. A. Hackney, Y. Ma, A. Smith, S. J. Sohn, H. Spits, R. D. Little, T. W. Behrens, et al. 2011. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One 6: e25038.
20. Oosting, M., H. ter Hofstede, F. L. van de Veerdonk, P. Sturm, B. J. Kullberg, J. W. van der Meer, M. G. Netea, and L. A. Joosten. 2011. Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease. Infect. Immun. 79: 4681-4687.
21. Hazlett, J., L. K. Stamp, T. Merriman, J. Highton, and P. A. Hessian. 2012. IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis. Genes Immun. 13: 282-287.
22. Di Meglio, P., F. Villanova, L. Napolitano, I. Tosi, M. Terranova Barberio, R. K. Mak, S. Nutland, C. H. Smith, J. N. Barker, J. A. Todd, and F. O. Nestle. 2013. The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patients. J. Invest. Dermatol. 133: 2381-2389.
23. Watakabe, A., K. Tanaka, and Y. Shimura. 1993. The role of exon sequences in splice site selection. Genes Dev. 7: 407-418.
24. Cooper, T. A., and W. Mattox. 1997. The regulation of splice-site selection, and its role in human disease. Am. J. Hum. Genet. 61: 259-266.
25. Woodley, L., and J. Valcárcel. 2002. Regulation of alternative pre-mRNA splicing. Brief. Funct. Genomics Proteomics 1: 266-277.
26. Lin, S., and X. D. Fu. 2007. SR proteins and related factors in alternative splicing. Adv. Exp. Med. Biol. 623: 107-122.
27. Shiga, N., Y. Takeshima, H. Sakamoto, K. Inoue, Y. Yokota, M. Yokoyama, and M. Matsuo. 1997. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J. Clin. Invest. 100: 2204-2210.
28. Vuillaumier-Barrot, S., A. Barnier, M. Cuer, G. Durand, B. Grandchamp, and N. Seta. 1999. Characterization of the 415G.A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping. Hum. Mutat. 14: 543-544.
29. Aschard, H., E. Bouzigon, E. Corda, A. Ulgen, M. H. Dizier, F. Gormand, M. Lathrop, F. Kauffmann, and F. Demenais. 2009. Sex-specific effect of IL9 polymorphisms on lung function and polysensitization. Genes Immun. 10: 559-565.
30. Grundtner, P., S. Gruber, S. S. Murray, S. Vermeire, P. Rutgeerts, T. Decker, P. L. Lakatos, and C. Gasche. 2009. The IL-10R1 S138G loss-of-function allele and ulcerative colitis. Genes Immun. 10: 84-92.
31. Moors, M., N. K. Vudattu, J. Abel, U. Krämer, L. Rane, N. Ulfig, S. Ceccatelli, V. Seyfert-Margolies, E. Fritsche, and M. J. Maeurer. 2010. Interleukin-7 (IL-7) and IL-7 splice variants affect differentiation of human neural progenitor cells. Genes Immun. 11: 11-20.
32. Kan, S. H., G. Mancini, and G. Gallagher. 2008. Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes. Genes Immun. 9: 631-639.
33. Mancini, G., S. H. Kan, and G. Gallagher. 2008. A novel insertion variant of the human IL-23 receptor-α chain transcript. Genes Immun. 9: 566-569.
34. Yu, R. Y., and G. Gallagher. 2010. A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells. J. Immunol. 185: 7302-7308.
35. Long, J. C., and J. F. Caceres. 2009. The SR protein family of splicing factors: master regulators of gene expression. Biochem. J. 417: 15-27.
36. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
37. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
38. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
39. Elder, J. T. 2009. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. Genes Immun. 10: 201-209.